Eclipse Treatment Planning System, ARIA Radiation Oncology (treatment plan and image management application) and Acuity Radiation Therapy Simulator Software versions 11 and 13 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 Varian Medical Systems Australasia Pty Ltd 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2013-RN-01301-1
  • 사례 위험등급
    Class I
  • 사례 시작날짜
    2013-12-10
  • 사례 국가
  • 사례 출처
    DHTGA
  • 사례 출처 URL
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • 데이터 추가 비고
  • 원인
    A software anomaly has been identified with the plan parameters workspace within eclipse treatment planning system, aria, and acuity. when a dose relevant parameter is changed and "do not clear mus and reference point dose" is selected, the monitor units (mus) may change without the user being aware of the changes. when the user follows a specific set of conditions, the dose is rescaled such that the 100% isodose is shifted to the primary reference point location. consequently, the mus for each treatment field will change and will not meet the dose prescription intended. for example, if the dose prescription percentage was 85% in the original plan, and a dose relevant parameter is changed, the dose prescription percentage will rescale to 100%. the monitor units will be correspondingly increased. thus, the plan will no longer meet the intended dose prescription.
  • 조치
    Users are advised not to use the Plan Parameters workspace to modify 3D Treatment Plans containing a 3D dose. When it is necessary to edit patient treatment plans containing 3D dose, this action must be performed in Eclipse External Beam Planning or in the applicable treatment planning system. Varian Medical Systems recommends a thorough review of treated patient plans for plans with a primary reference point with geometric location and where modifications were made in the Plan Parameter workspace. Varian Medical Systems is currently developing a technical correction for this issue. This action has been closed-out on 11/02/2016.

Device

  • 모델명 / 제조번호(시리얼번호)
    Eclipse Treatment Planning System, ARIA Radiation Oncology (treatment plan and image management application) and Acuity Radiation Therapy SimulatorSoftware versions 11 and 13Product codes: H48, HIT and H77ARTG Numbers: 119983, 132638, 119995
  • 의료기기 분류등급
  • Manufacturer

Manufacturer